2025

Publikationsliste med Link til abstract.

  • Nguyen HTT, Stoico MP, Le VQ, Thomsen JHD, Krarup KB, Kristjansen KA et al. Metabolic signature of COVID-19 progression: potential prognostic markers for severity and outcome. Metabolomics. 2025 maj 21;21(3):70. doi: 10.1007/s11306-025-02264-w PMID:40399692:

  • Watson H, Jepsen P, Vilstrup H, Krarup H. Delta in Denmark: prevalence of hepatitis delta virus infection. Infectious Diseases. 2025 feb.;57(2):202-206. Epub 2024 dec. 17. doi: 10.1080/23744235.2024.2434887 PMID:39688885
  • Kostov AM, Jensen MB, Ejlertsen B, Thomassen M, Rossing CM, Pedersen IS et al. Germline BRCA testing in Denmark following invasive breast cancer: Progress since 2000. Acta Oncologica. 2025 jan. 28;64:147-155. doi: 10.2340/1651-226X.2025.42418 PMID:39876688:

  • Mapendano CK, Nøhr AK, Sønderkær M, Pagh A, Carus A, Lörincz T et al. Longer survival with precision medicine in late-stage cancer patients. ESMO Open. 2025 jan.;10(1):104089. 104089. Epub 2025 jan. 3. doi: 10.1016/j.esmoop.2024.104089 PMID:39754975
  • Vogel I, Andreasen L, Balslev-Harder M, Becher N, Ernst A, Gadsbøll K, et al. Whole Genome Sequencing in Prenatal Diagnostics: The Danish Approach to Guideline Formation and Implementation Within Public Healthcare. Prenatal diagnosis [Internet]. 2025 Autumn;10.1002/pd.6780. PMID:40122702
  • Stubbe B, Stoico MP, Terp SK, Madsen PH, Lundbye-Christensen S, Hansen CP et al. Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma. Frontiers in Oncology. 2025;15:1568386. doi: 10.3389/fonc.2025.1568386 PMID:40492125

Opdateret